Estradiol [horm, phsu, strd]
Dydrogesterone [horm, phsu, strd]
Review [inpr]
Combined [qlco]
Hormone [horm]
Replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Focus [spco]
Review [inpr]
Hormone replacement therapy [topp]
Continuous [idcn]
Oral [spco]
referred [ftcn]
To [qlco]
Estradiol [horm, phsu, strd]
mg day [qnco]
Sequential [idcn]
Oral [spco]
Dydrogesterone [horm, phsu, strd]
mg day [qnco]
days [tmco]
Cycle [tmco]
Data [idcn]
Trial [resa]
Regimen [topp]
Relieves [ftcn]
Climacteric [orgf]
symptoms [ftcn]
Bone Mineral Density [clna]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Profile [lbpr]
postmenopausal [tmco]
Women [popg]
increases [ftcn]
Mean [qnco]
Bone Mineral Density [clna]
Lumbar spine [bpoc]
Reported [inpr]
treatment [ftcn]
Effect [qlco]
Bone Mineral Density [clna]
Oral [spco]
Estradiol [horm, phsu, strd]
Sequential [idcn]
Dydrogesterone [horm, phsu, strd]
Similar [qlco]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Sequential [idcn]
Oral [spco]
Dydrogesterone [horm, phsu, strd]
Oral [spco]
tibolone [phsu, strd]
Good [qlco]
Protection [fndg]
Endometrial Hyperplasia [dsyn]
Cancer [neop]
Provided [acty]
Dydrogesterone [horm, phsu, strd]
Component [mnob]
Cyclical [tmco]
Vaginal Bleeding [patf]
Occur [acty]
treatment [ftcn]
Cycle [tmco]
Light [npop]
Moderate [qlco]
Time [tmco]
Onset [qlco]
Highly [qlco]
Predictability [menp]
Bleeding [patf]
Occur [acty]
Cycle [tmco]
Mean [qnco]
Serum [bdsu]
High density lipoprotein cholesterol level [lbpr]
Increased [qnco]
Low density lipoprotein cholesterol level [lbpr]
Decreased [qnco]
treatment [ftcn]
Oral [spco]
Estradiol [horm, phsu, strd]
Sequential [idcn]
Dydrogesterone [horm, phsu, strd]
Insulin Resistance [patf]
APPEAR [qlco]
To [qlco]
Improved [qlco]
Blood Pressure [orgf]
Body Weight [orga]
Not [ftcn]
Affected [ftcn]
Extent [spco]
Serum homocystine level [lbpr]
Reported [inpr]
To [qlco]
Decrease [qlco]
postmenopausal [tmco]
Women [popg]
High [qlco]
Pretreatment [sbst]
Level [qlco]
Data [idcn]
Available [ftcn]
General [spco]
TOLERABILITY [resa]
Profile [lbpr]
Regimen [topp]
adverse events [fndg]
Most [qnco]
LED [mnob]
Discontinuation [hlca]
treatment [ftcn]
Clinical Trials [resa]
Associated [qlco]
Hormone replacement therapy [topp]
Including [ftcn]
Vaginal Bleeding [patf]
Headache [sosy]
Bloating [sosy]
Breast tenderness [sosy]
Risk [qlco]
Breast Cancer [neop]
Not [ftcn]
Assessed [acty]
Regimen [topp]
Unlikely [cnce]
Carry [acty]
Risk [qlco]
Hormone replacement therapy [topp]
regimens [inpr]
summary [inpr]
Available [ftcn]
Data [idcn]
treatment [ftcn]
Continuous [idcn]
Oral [spco]
Estradiol [horm, phsu, strd]
Sequential [idcn]
Dydrogesterone [horm, phsu, strd]
effective [qlco]
relieving [ftcn]
Climacteric [orgf]
symptoms [ftcn]
Preserving [ftcn]
Bone Mineral Density [clna]
postmenopausal [tmco]
Women [popg]
Dydrogesterone [horm, phsu, strd]
Component [mnob]
Good [qlco]
Endometrial [spco]
Protection [fndg]
Cycle [tmco]
Control [grup]
CARDIOVASCULAR [bdsy]
Benefits [qnco]
Estradiol [horm, phsu, strd]
Comparison [acty]
Standard [qlco]
Hormone replacement therapy [topp]
regimens [inpr]
Long-term [tmco]
Data [idcn]
Including [ftcn]
Clinical [qlco]
End Point [qlco]
Needed [qlco]
Regimen [topp]
Acceptable [qlco]
Hormone replacement therapy [topp]
Option [ftcn]
